Ribosomal protein L22 pseudogene 23 (RPL22P23)

Ribosomal protein L22 pseudogene 23 (RPL22P23) is classified as a processed pseudogene related to the ribosomal protein L22 gene family. Unlike protein-coding genes, RPL22P23 does not encode a functional protein product and is not considered a therapeutic or drug discovery target. Pseudogenes such as RPL22P23 are typically remnants of gene duplication or retrotransposition events and generally lack biological function due to disabling mutations or the absence of necessary regulatory elements[1][4]. There is no evidence connecting RPL22P23 to disease roles, drug interactions, or biomarker applications. The functional ribosomal protein L22 (encoded by RPL22) is involved in ribosome structure and protein synthesis, but this is not true for its pseudogenes, including RPL22P23[1][4].

Other names

RPL22P23